Rev Bras Oftalmol.2012;71(2):84-88

Eficacy of intraoperative use of mitomycin C pterygium surgery: analysis of 102 cases

Rodrigo Salustiano Correa e , Marcos Pereira de , Álcio Coutinho de , Leiser Franco de Morais , Bruna Thomé

DOI: 10.1590/S0034-72802012000200003

PURPOSE: Measure of efficacy and the security of intraoperative of mitomycin C (MMC) in the pterygium surgery. METHODS: Realized prospective analysis of 102 patients (204 eyes) divided in two groups submitted intraoperative MMC 0.02 % for 2 minutes or saline solution 0.9%. The patients were available in 1º, 7 º, 21º, 30º, 60º and 90º days of postoperative. RESULTS: The pterygium was more prevalence in females (58,33%). The age various 33 to 69 years. The recidive (9) was in the 90º PO in the group of MMC. In the control group was identificated two recidives in 60 days. The complications found in MMC group were: ceratitis, lips edema, dehiscence of suture, ischemia, granuloma, corneal dellen and simblefaro. CONCLUSION: The use of MMC was useful in reducing the rate of recurrence in pterygium compared to the use of saline solution, but its harmful effects must always be evaluated.

Eficacy of intraoperative use of mitomycin C pterygium surgery: analysis of 102 cases

Comments (0)